The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs’ cost should be covered by Medicare, Medicaid and private insurers. Late last month, the Biden administration proposed that the drugs be covered by Medicare and Medicaid, a move that would have to be approved by the… read on > read on >
A California dairy farm has expanded a recall of its raw milk and cream after state health officials discovered bird flu virus in more milk samples. In a notice posted Tuesday, Fresno-based Raw Farm LLC said it has now recalled all whole milk and cream products with “use by” dates of Nov. 27 to Dec.… read on > read on >
Holiday travel is always stressful, but particularly so for people with food allergies. Airlines don’t always honor requests to protect the health of people with food allergies during flights, a new study published Dec. 5 in the Journal of Allergy and Clinical Immunology. found. Many people with food allergies say that airlines promise to take… read on > read on >
Fatty liver disease may contribute to fragmented sleep patterns, robbing already sick people of good rest, a new study finds. These folks woke up more often in the night, and then lay awake longer waiting for slumber to reclaim them, researchers found. These patients also reported taking longer to get to sleep. And their sleep… read on > read on >
The sugar known as fructose could be a kind of rocket fuel for cancer cells, and lowering fructose intake could be one way to fight the disease, new research suggests. Fructose is already ubiquitous in American diets, due to the heavy use of super-sweet high-fructose corn syrup in products folks eat every day. “If you… read on > read on >
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. “Given the increased interest around obesity medications, we conducted this study to help health care providers and patients make informed decisions about treatment choice,” Dr. Leonard Glass, senior vice president of… read on > read on >
WEDNESDAY, Dec. 4, 2024 (Healtday News) — An investigation into an E. coli outbreak linked to McDonald’s Quarter Pounders has officially been closed, the U.S. Food and Drug Administration announced Tuesday. In total, 104 people from 14 states were sickened and 34 were hospitalized during the outbreak, while one older person in Colorado died, the… read on > read on >
Taking even high doses of supplementary vitamin D won’t lower an older person’s odds for type 2 diabetes, new research confirms. Vitamin D supplements may have other benefits, but in otherwise healthy folks with sufficient levels of the nutrient, “our findings do not suggest benefits of long-term moderate- or high-dose vitamin D3 supplementation” in warding off… read on > read on >
GLP-1 meds are all the rage for weight loss nowadays, but not everyone can safely take the drugs to shed pounds. Invasive weight-loss surgeries can often be a tough sell, too. Now, researchers at the Massachusetts Institute of Technology (MIT) say they’ve developed an alternative: A small, implanted gastric balloon that people can inflate or… read on > read on >
An accumulation of fat lurking around the organs of obese people is strongly linked to a buildup of Alzheimer’s-linked proteins in the brain, new research finds. Buildup of this visceral fat in middle age may boost levels of the two damaging brain proteins, called amyloid and tau, explained a team led by Dr. Mahsa Dolatshahi,… read on > read on >
-300x169.jpg)
